<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/abus" ></link>
<id>urn:uuid:71833c5b-8116-bb5f-a286-443406365763</id>
<updated>2026-05-12T21:10:58-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ABUS: NGUYEN TUAN (CFO) Acquired (JB) 73,500 Shares of ARBUTUS BIOPHARMA CORP for $0.00 on 2/2</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6316764" ></link>
<id>urn:uuid:92aa65eb-633d-b0fc-f99a-cd72bf8378eb</id>
<updated>2026-02-02T20:21:34-05:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.34. Mkt Cap:854.7mm. 10D Vol: 1.3mm]]></summary>
</entry>
<entry>
<title>ABUS: ANDROSKI LINDSAY (PR,CEO,DIR) Acquired (JB) 28k Shares of ARBUTUS BIOPHARMA CORP for $0.00 on 2/2</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6316765" ></link>
<id>urn:uuid:1a211eff-1421-5f30-7b39-5f621ef7d579</id>
<updated>2026-02-02T20:21:13-05:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.34. Mkt Cap:854.7mm. 10D Vol: 1.3mm]]></summary>
</entry>
<entry>
<title>ABUS: SAWHNEY ROGER (DIR) Filed a Form 3, Becoming a Registered Insider at ARBUTUS BIOPHARMA CORP With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6236634" ></link>
<id>urn:uuid:45e72f0a-1f01-d140-05f0-1e01e0817603</id>
<updated>2025-08-06T16:06:24-04:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.34. Mkt Cap:854.7mm. 10D Vol: 1.3mm]]></summary>
</entry>
<entry>
<title>ABUS: NGUYEN TUAN (CFO) Filed a Form 3, Becoming a Registered Insider at ARBUTUS BIOPHARMA CORP With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6174993" ></link>
<id>urn:uuid:2e090b37-b7af-ec52-fd07-e0ab2eea266a</id>
<updated>2025-03-31T16:21:38-04:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.34. Mkt Cap:854.7mm. 10D Vol: 1.3mm]]></summary>
</entry>
<entry>
<title>ABUS: HASIJA ANUJ (DIR) Filed a Form 3, Becoming a Registered Insider at ARBUTUS BIOPHARMA CORP With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6157813" ></link>
<id>urn:uuid:d23a6e5e-cba8-07b3-44e6-dcc4956d7d65</id>
<updated>2025-03-06T16:13:29-05:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.34. Mkt Cap:854.7mm. 10D Vol: 1.3mm]]></summary>
</entry>
<entry>
<title>ABUS: BISHOP JOSEPH E (DIR) Filed a Form 3, Becoming a Registered Insider at ARBUTUS BIOPHARMA CORP With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6157809" ></link>
<id>urn:uuid:303b19b7-1de8-4503-5cff-146f3999cd1e</id>
<updated>2025-03-06T16:11:44-05:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.34. Mkt Cap:854.7mm. 10D Vol: 1.3mm]]></summary>
</entry>
<entry>
<title>ABUS: BEARDSLEY ROBERT A (DIR) Filed a Form 3, Becoming a Registered Insider at ARBUTUS BIOPHARMA CORP With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6157807" ></link>
<id>urn:uuid:f85d7a97-84f6-cb82-edf8-3c8a6d9f7176</id>
<updated>2025-03-06T16:10:27-05:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.34. Mkt Cap:854.7mm. 10D Vol: 1.3mm]]></summary>
</entry>
<entry>
<title>ABUS: ANDROSKI LINDSAY (PR,CEO,DIR) Filed a Form 3, Becoming a Registered Insider at ARBUTUS BIOPHARMA CORP With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6157806" ></link>
<id>urn:uuid:69f77ec1-3685-b4a7-ef7c-ebb27d6f29f5</id>
<updated>2025-03-06T16:08:38-05:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.34. Mkt Cap:854.7mm. 10D Vol: 1.3mm]]></summary>
</entry>
<entry>
<title>ABUS: GLINE MATTHEW (DIR,BO) Filed a Form 3, Becoming a Registered Insider at ARBUTUS BIOPHARMA CORP With Initial Indirect Holdings of 38.8mm</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6157805" ></link>
<id>urn:uuid:c17f132b-76c5-c131-2a34-312e0821df90</id>
<updated>2025-03-06T16:07:01-05:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.34. Mkt Cap:854.7mm. 10D Vol: 1.3mm]]></summary>
</entry>
<entry>
<title>ABUS: NAFTZGER J CHRISTOPHER (GC,CCO) Acquired (JB) 54,300 Shares of ARBUTUS BIOPHARMA CORP for $0.00 on 2/14</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6137252" ></link>
<id>urn:uuid:922a95ae-b3bf-74af-48a3-117a2b1d3a2e</id>
<updated>2025-02-19T18:25:53-05:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.34. Mkt Cap:854.7mm. 10D Vol: 1.3mm]]></summary>
</entry>
</feed>